MedPath

OSPM-Enhanced AI Model to Identify Premalignant and Malignant Ocular Surface Tumors

Completed
Conditions
Performance of the Model
Registration Number
NCT06567028
Lead Sponsor
Ningbo Eye Hospital
Brief Summary

An OSPM-enhanced deep learning model has been developed for identifying premalignant and malignant tumors using data retrospectively collected from the Ningbo Eye Hospital, Jiangdong Eye Hospital, and the Eye Hospital of Wenzhou Medical University. To further substantiate the model's effectiveness, we intend to evaluate it prospectively at Ningbo Eye Hospital.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria

Ocular surface tumor images with histopathological findings

Exclusion Criteria

Low-quality images

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
AUROC3 months

area under the receiver operating characteristic curve

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ningbo Eye Hospital

🇨🇳

Ningbo, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath